This cost-of-illness analysis is part of a Europe-wide study on the costs of multiple sclerosis
(MS) and is based on information from patients in Austria. The objective was to estimate the …

INTRODUCTION: Poor specific economic information are available for the different Multiple
Sclerosis (MS) courses: relapsing remitting (RRMS), secondary progressive (SPMS) and …

Aims: To estimate costs of multiple sclerosis (MS) in a German cohort according to severity
of the disease and clinical symptoms. Methods: 144 patients were recruited from an MS …

Background Medical therapy for multiple sclerosis (MS) is expensive. Quantifying the burden
of MS is fundamental for health-care planning and the allocation of resources for the …

Background Cost-of-illness (COI) studies of Multiple Sclerosis (MS) are vital components for
describing the economic burden of MS, and are frequently used in model studies of …

Background The objective of this study was to estimate costs to society and patients' quality
of life (QoL) at all levels of disease severity (measured with the Expanded Disability Status …

This cost-of-illness analysis based on information from 2973 patients with multiple sclerosis
(MS) in Germany is part of a Europe-wide study on the costs of MS. The objective was to …

Objectives The aim of this study is to estimate the cost of illness (COI) from a societal
perspective of all multiple sclerosis (MS) patients of working ages in Sweden, and to explore …

A cross-sectional cost-of-care study was performed to assess the economic burden of
multiple sclerosis (MS) in France, Germany and the UK. Patients were stratified into 3 groups …

Multiple sclerosis (MS) is a progressive, chronic disease of the central nervous system (brain
and spinal cord). It is the most frequent neurological disease in young and middle-aged …